Table 1.
Characteristics of selected studies from Iranian patients
| Studies | Publication year | Location | Sample size (N) | MDR N (%) | Int1 in total N (%) | Units | Correlation* |
|---|---|---|---|---|---|---|---|
| Moradian Kouchaksaraei F, et al (23) | 2013 | Babol | 54 | 53 (98.1) | 20 (37) | ICU | Yes |
| Aryanezhad M, et al (24) | 2016 | Bandar Abbas | 90 | 12(13.3) | 12(13.3) | ICU, non-ICU | yes |
| Mohammadzadeh A, et al (36) | 2017 | Gonabad | 95 | - | 29 (30.5) | Different wards | - |
| Mobaraki S, et al (2) | 2018 | Tabriz | 200 | 106(53) | 55 (27.5) | Different wards | Yes |
| Faghri J, et al (18) | 2018 | Isfahan | 72 | - | 40(55.6) | ICU, non-ICU | Yes |
| Goli HR, et al (26) | 2018 | Tabriz | 57 | 57(100) | 57(99.1) | ICU | Yes |
| Pournajaf A, et al (37) | 2018 | Different | 143 | 12(8.4) | 27(18.9) | CF Patient (Iran) | - |
| Salimizadeh Z, et al (38) | 2018 | Tehran | 21 | 21(100) | 19(90.5) | Different wards | Yes |
*
Correlation between Int1 and antibiotic resistance, ICU: Intensive care unit, CF: Cystic fibrosis.